T1	Participants 74 192	patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
T2	Participants 528 575	patients with persistent allergic rhinitis (AR)
T3	Participants 780 810	40 patients with persistent AR
